Taro announces merger with Sun Pharma in ₹2,892 crore deal

Upon completion of the merger, currently expected to close in the first half of 2024, Taro will become a privately held company and its shares will no longer be listed on the NYSE.

from | The Hindu https://ift.tt/9mN4xYD